2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
Antitrust
| Competition & Antitrust — Highly Recommended |
|---|
| Arnold & Porter |
| Cleary Gottlieb Steen & Hamilton |
| Gibson Dunn & Crutcher |
| Goldman Ismail Tomaselli Brennan & Baum |
| Latham & Watkins |
| Weil Gotshal & Manges |
| White & Case |
| Competition & Antitrust — Recommended |
|---|
| Covington & Burling |
| Dechert |
| McDermott Will & Emery |
| Morgan Lewis & Bockius |
| Patterson Belknap Webb & Tyler |
| Ropes & Gray |
| Sidley Austin |
General Patent Litigation
| General Patent Litigation — Recommended |
|---|
| Arnold & Porter |
| Cooley |
| Covington & Burling |
| Durie Tangri |
| Gibson Dunn & Crutcher |
| Knobbe Martens |
| Mayer Brown |
| McAndrews Held & Malloy |
| Morgan Lewis & Bockius |
| Sterne Kessler Goldstein & Fox |
| Venable |
| Weil Gotshal & Manges |
Product Liability
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Aiello, Michael | Financial & Corporate | Mergers & Acquisitions | New York City |
| Buchweitz, Yehudah | Non-IP Litigation & Enforcement | Antitrust | New York City |
| Gietz, Raymond | Financial & Corporate | Mergers & Acquisitions | New York City |
| Malester, Ann | Washington, D.C. | ||
| Neuwirth, John | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | New York City |
| Newborn, Steven | Non-IP Litigation & Enforcement | Antitrust | Washington, D.C. |
| Osterman, Jeffrey | Financial & Corporate | Licensing & Collaboration | New York City |
| Reines, Edward R | Intellectual Property | General Patent Litigation | Redwood Shores |
| Sandhu, Charan J | Financial & Corporate | Licensing & Collaboration, Mergers & Acquisitions | New York City |
| Sullivan, Diane | Non-IP Litigation & Enforcement | Product Liability | New York City |
| Weiswasser, Elizabeth | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Weil Gotshal & Manges
Weil Gotshal & Manges is nationally ranked for its expertise in general patent litigation. The firm's IP litigation team is active in several technology areas, including pharmaceuticals, biologics, diagnostics and the burgeoning genetic testing space.
Renowned IP lawyer Edward Reines is co-head of the firm's patent litigation practice and life sciences industry group. He has significant first-chair experience in patent disputes, and is particularly known for his effectiveness in appeals. Reines recently acted for Bio-Rad Laboratories and the University of Chicago in a litigation brought against 10X Genomics, resulting in a an upheld $24 million patent jury verdict in favor of the clients. Reines was shortlisted in 2020 for the General Patent Litigator of the Year award in California.
Patent litigation and life sciences group co-head Elizabeth Weiswasser is an acclaimed attorney for high-stakes IP trials. In one matter, she is representing Sanofi in IPR proceedings and district litigation related to its branded Lantus insulin products. Weiswasser is also active for Johnson & Johnson subsidiary Ethicon in a patent infringement suit before the ITC. For her work in the area, Weiswasser was shortlisted for the General Patent Litigator of Year award in New York.